It depends on how you look at it. In the 10QSB from Nov 19, 2007 they stated the following:
"At any time, holders may convert the Debentures into shares of common stock at a fixed conversion price of $0.84, subject to adjustment in the
event we issue common stock (or securities convertible into or exercisable for common stock) at a price below the conversion price as such price
may be in effect at various times (the “Conversion Price”)."
I am assuming this means they issued more common stock at a price of $0.60. If this is what has occurred then it is in line with what I have been expecting. Cryoport needs more capital to fully implement the business plan. It seems like they are finalizing the last bit to execute that plan. In my mind this is a good event only because they have at least 1 million plus still on the books so they don't need that capital currently; unless some large orders have been placed and they needed the money to fund the production of the shippers for these orders.
just my two cents, do your own DD.
"At any time, holders may convert the Debentures into shares of common stock at a fixed conversion price of $0.84, subject to adjustment in the
event we issue common stock (or securities convertible into or exercisable for common stock) at a price below the conversion price as such price
may be in effect at various times (the “Conversion Price”)."
I am assuming this means they issued more common stock at a price of $0.60. If this is what has occurred then it is in line with what I have been expecting. Cryoport needs more capital to fully implement the business plan. It seems like they are finalizing the last bit to execute that plan. In my mind this is a good event only because they have at least 1 million plus still on the books so they don't need that capital currently; unless some large orders have been placed and they needed the money to fund the production of the shippers for these orders.
just my two cents, do your own DD.
Recent CYRX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 06:36:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:30:40 PM
- Cryoport Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/04/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/24/2026 12:00:17 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/22/2026 08:32:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:31:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 08:30:45 PM
- Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026 • PR Newswire (US) • 04/20/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 10:32:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:01:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 12:00:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:01:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 12:00:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/12/2026 08:17:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 10:10:46 PM
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results • PR Newswire (US) • 03/03/2026 09:05:00 PM
- Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026 • PR Newswire (US) • 02/17/2026 01:00:00 PM
- Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series • PR Newswire (US) • 02/11/2026 01:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/05/2026 09:56:32 PM
